Riviciclib

A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively.

920113-03-7

≥ 2 years

>98% (HPLC)

438.3

C21H20ClNO5.HCl

Research use only, not for human use.

CDK1/CyclinB| CDK2/CyclinA| CDK4/CyclinD1| CDK6/CyclinD3| CDK9/CyclinT1

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP1-76311AF488 0.1 mL

Ask

524835-01 100 µL

Ask

524835-02 200 µL

Ask

SR300748 1 Kit

Ask

AMM12926VCF 100 µg

Ask

RR205322L3 10 µg

Ask